Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 13/20 | 1.00 |
| ▸ | P2RY6 | Q15077 | 8/20 | 1.00 |
| ▸ | P2RY2 | P41231 | 7/20 | 1.00 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine Diphosphate Glucose SCHEMBL1521087 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL1521097 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL1521147 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL15589310 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL14389090 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL14534383 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL24747518 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL15314069 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL20680471 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 | |
| Uridine Diphosphate Glucose SCHEMBL12016941 | 1.00 | P2RY14 (1.00) | P2RY14P2RY6P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| EP-4437319-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | Matterworks Inc (US) | 2024-10-02 | — | — | EP | claimed |
| WO-2023077166-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC (US) | 2023-05-04 | — | — | WO | claimed |
| US-20230137741-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC | 2023-05-04 | — | — | US | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |
| CN-122095952-A | Polygonatum sibiricum planting method capable of reducing allelochemicals and improving polysaccharide content | — | 2026-05-29 | — | — | CN | disclosed |
| US-20260148950-A1 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | MATTERWORKS INC (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4655305-B1 | RUTHENIUM COMPLEXES FOR INHIBITION OF GALECTINS, METHOD OF THEIR PREPARATION, AND USE THEREOF | USTAV CHEMICKYCH PROCESU AV CR V V I (CZ) | 2026-05-13 | — | — | EP | disclosed |
| US-20260109729-A1 | RUTHENIUM COMPLEXES FOR INHIBITION OF GALECTINS, METHOD OF THEIR PREPARATION, AND USE THEREOF | USTAV CHEMICKYCH PROCESU AV CR V V I (CZ) | 2026-04-23 | — | — | US | disclosed |
| US-12565666-B2 | Methods and compositions for modulating a genome | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2026-03-03 | — | — | US | disclosed |
| CN-114196690-A | Fluorodorside anabolism combined gene and combined enzyme | 中国海洋大学 | 2022-03-18 | — | — | CN | disclosed |
| CN-114207108-A | Genetically modified host cells producing glycosylated cannabinoids | 奥克塔林生物制剂公司 | 2022-03-18 | — | — | CN | disclosed |
| US-11274312-B2 | Genes and uses for plant enhancement | MONSANTO TECHNOLOGY LLC (US) | 2022-03-15 | — | — | US | disclosed |
| WO-2022034069-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL FUCOSYLATED OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | disclosed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | disclosed |
| US-5550155-A | ANTIINFLAMMATORY AGENTS | ALBERTA RESEARCH COUNCIL (CA) | 1996-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109729-A1 | RUTHENIUM COMPLEXES FOR INHIBITION OF GALECTINS, METHOD OF THEIR PREPARATION, AND USE THEREOF | LGALS1, LGALS2, LGALS3 | P2RY14 3657/4885P2RY6 1913/4885P2RY2 1964/4885 |
| US-20260148950-A1 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | SRMS, PTMS, CALCB | P2RY14 1041/4885P2RY6 2350/4885P2RY2 1204/4885 |
| US-12565666-B2 | Methods and compositions for modulating a genome | RPRD2, ERN2, TPR | P2RY14 4602/4885P2RY6 4800/4885P2RY2 4749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.